This month, Congressman Bob Latta (R-OH5) introduced H.R. 5833, legislation working to increase accessibility to non-opioid treatment for those suffering from chronic pain. People who are suffering from chronic pain often turn to opioids to alleviate their discomfort, which in some cases, has led to a rise of misuse and abuse. Opioid alternatives, including certain medical devices and… Read more »
Today, U.S. Representatives Bob Latta (R-OH5) and Steve Chabot (R-OH1) introduced legislation to provide the U.S. Drug Enforcement Administration (DEA) the ability to criminalize the manufacturing, distribution or possession of fentanyl-like drugs. Specifically, H.R. 5771, the Federal Initiative to Guarantee Health by Targeting (FIGHT) Fentanyl Act, will… Read more »
Today, Congressman Bob Latta (R-OH5) joined the Energy and Commerce Subcommittee on Oversight and Investigations to further examine the state efforts underway to curb the opioid crisis and to shine a spotlight on the importance of legislation Latta authored, the Indexing Narcotics, Fentanyl and Opioids (INFO) Act. The INFO Act was a core part of H.R.6, the SUPPORT Act, that was… Read more »
Click HERE to watch Congressman Latta speak on the House floor in support of the bipartisan Lower Costs, More Cures Act.
Today, Congressman Bob Latta (R-OH5) voted against H.R.3, a partisan bill that would result in fewer cures, would harm innovation, and will never become law. Instead, Congressman Latta voted in support of H.R. 19, the Lower Costs, More Cures Act, a bipartisan… Read more »
Congressman Bob Latta (R-OH5) penned an op-ed in the Lima News shining a spotlight on the Lower Costs, More Cures Act, a bipartisan plan for lowering the costs of prescription medications for people across the country.
Bipartisan plan better for people needing medicine
By: Congressman Bob Latta (R-OH5)
December 11, 2019
As the cost of prescription drugs… Read more »
Today, the Energy and Commerce Committee concluded a two-day markup where members voted to pass a number of bipartisan bills working to improve health care access for new and expecting mothers, increase rural broadband capabilities, boost our economy, and more. Congressman Latta released the following statement at the conclusion of today’s markup:
“The bipartisan bills the Committee… Read more »
On the one year anniversary of President Trump signing H.R. 6, the SUPPORT Act, into law, Congressman Bob Latta (R-Bowling Green) has introduced two new pieces of legislation to address the opioid crisis. Legislation that Latta had previously authored, the Indexing Narcotics, Fentanyl, and Opioids (INFO) Act, was included in H.R. 6. The Department of Health and Human Services is currently… Read more »
Congressman Bob Latta (R-Bowling Green) authored a column in today’s Findlay Courier that reflects on the progress made to curb the opioid epidemic in the last year. On October 24, 2018, President Trump signed H.R. 6, the SUPPORT Act into law. That legislation was the most comprehensive effort to combat a drug crisis in U.S. history.
The article can be seen in the Ecourier edition… Read more »
Congressman Bob Latta (R-Bowling Green) today voted against the poorly named Protecting Americans with Preexisting Conditions Act of 2019 (H.R. 986). Under the guise of protecting people with pre-existing conditions, this legislation would strip away states’ ability to innovate in their health care systems.
The innovation waivers targeted in this misnomer of a bill were created… Read more »
On Friday, Congressman Bob Latta (R-Bowling Green) joined medical personnel for a roundtable discussion on the opioid crisis at Blanchard Valley Hospital in Findlay. The discussion focused on improving treatment options, pain management practices, and the potential effect of comprehensive opioid legislation, H.R. 6. That legislation passed at the end of last year and is… Read more »
